Cloning and characterization of the mouse Mcoln1 gene reveals an alternatively spliced transcript not seen in humans
- John L Falardeau†1, 3,
- John C Kennedy†1, 3,
- James S AciernoJr1, 3,
- Mei Sun2,
- Stefanie Stahl2,
- Ehud Goldin2 and
- Susan A Slaugenhaupt1, 3Email author
© Falardeau et al; licensee BioMed Central Ltd. 2002
Received: 27 November 2001
Accepted: 05 February 2002
Published: 05 February 2002
Mucolipidosis type IV (MLIV) is an autosomal recessive lysosomal storage disorder characterized by severe neurologic and ophthalmologic abnormalities. Recently the MLIV gene, MCOLN1, has been identified as a new member of the transient receptor potential (TRP) cation channel superfamily. Here we report the cloning and characterization of the mouse homologue, Mcoln1, and report a novel splice variant that is not seen in humans.
The human and mouse genes display a high degree of synteny. Mcoln1 shows 91% amino acid and 86% nucleotide identity to MCOLN1. Also, Mcoln1 maps to chromosome 8 and contains an open reading frame of 580 amino acids, with a transcript length of approximately 2 kb encoded by 14 exons, similar to its human counterpart. The transcript that results from murine specific alternative splicing encodes a 611 amino acid protein that differs at the c-terminus.
Mcoln1 is highly similar to MCOLN1, especially in the transmembrane domains and ion pore region. Also, the late endosomal/lysosomal targeting signal is conserved, supporting the hypothesis that the protein is localized to these vesicle membranes. To date, there are very few reports describing species-specific splice variants. While identification of Mcoln1 is crucial to the development of mouse models for MLIV, the fact that there are two transcripts in mice suggests an additional or alternate function of the gene that may complicate phenotypic assessment.
Mucolipidosis type IV (MLIV; MIM 252650) is an autosomal recessive lysosomal storage disorder that is characterized by corneal clouding, delayed psychomotor development, and mental retardation that usually presents during the first year of life . Another interesting clinical characteristic is that patients are constitutively achlorhydric with associated hypergastremia . Patients with MLIV do not show mucopolysaccharide excretion, skeletal changes, or organomegaly like the other mucolipidoses. Abnormal lysosomal storage bodies and large vacuoles have been found in skin and conjuctival biopsies using electron-microscopy and, prior to gene identification, served as the only means of diagnosis [3–5]. A recent report estimates that the carrier frequency of MLIV in the Ashkenazi Jewish population is 1 in 100, and mutations have been reported in Jewish and non-Jewish families [6–9].
The human gene MCOLN1 (GenBank #AF287270) maps to chromosome 19p13.2-13.3 and encodes a novel protein that is a member of the transient receptor potential (TRP) cation channel gene superfamily [7–10]. Protein trafficking studies suggest that MLIV is the result of a defect in the late endocytic pathway, contrary to the other mucolipidoses which are typically caused by defective lysosomal hydrolases [11, 12]. Recent work in Caenorhabditis elegans supports this hypothesis. Loss of function mutants of the MCOLN1 C. elegans homologue, cup-5, result in an increased rate of endocytosis, accumulation of large vacuoles, and a decreased rate of endocytosed protein breakdown; while over-expression of this gene reverses the phenotype . Cloning and characterization of the mouse homologue of MCOLN1 is crucial for the development of mouse models of MLIV to further study this disorder.
Results and discussion
Cloning and mapping of the mouse homologue Mcoln1
Three clones (ID Nos. 604971, 1228665, 1247566) from the UniGene cluster Mm. 8356 were obtained, sequenced, and assembled into a 2 kb transcript with an open reading frame of 580 amino acids designated Mcoln1 (GB No. AF302010). Comparison of the cDNA sequence to the BAC clone showed that the gene consists of 14 exons. We then created a transcript map of the Mcoln1 region of mouse chromosome 8 (Fig. 1B), noting the presence of the UniGene Cluster Mm. 39099, a homologue of the human zinc finger gene (GB No. AC001252) that terminates approximately 1.8 kb before the start of Mcoln1; and Nte, the mouse homologue of the human neuropathy target esterase gene (NTE) beginning 130 base pairs after the polyadenylation signal for Mcoln1. The transcript map of the region surrounding Mcoln1 is similar to the corresponding region of the homologous human MCOLN1 region , and the presence of the zinc finger gene and Nte confirms and extends the region of synteny between human chromosome 19 and mouse chromosome 8.
Characterization of Mcoln1
Expression analysis of Mcoln1
Characterization of the Mcoln1 alternative splice variant
In order to determine the coding sequence for the larger transcript, we searched the mouse EST database using each intron as well as the genomic sequence flanking the Mcoln1 gene. Two ESTs were identified that contained sequence from intron 12 (GB No. AI430291 and AA874645), and the corresponding clones were sequenced. Clone 408619 (ESTs: GB No. AI430291, AI429558) begins approximately 1.1 kb before exon 13 and continues through the exon and splices correctly to exon 14. Clone 1281641 (EST:GB No. AA874645) begins 175 bp before exon 13 and also splices correctly to exon 14. A mouse multiple tissue Northern was hybridized using a probe generated from the putative intron sequence in clone 408619 (Probe 2, Fig. 1B), which detected only the 4.4 kb band (Fig. 3C).
In order to determine the sequence of the entire transcript, RT-PCR using primers in exons 10 and 11 paired with a primer in intron 12 was performed using BALB/c mouse brain total RNA and the resulting products sequenced. These products show that the larger transcript is due to an alternative splice event that results in an expanded exon 13. Specifically, exon 12 splices at bp 436 of intron 12, creating a large 1614 bp exon 13 that splices correctly to exon 14. The open reading frame of this alternatively spliced transcript is 611 amino acids, 28 amino acids longer than the message encoded by the 2.4 kb transcript.
Next, we directly compared the nucleotide and amino acid sequence of the alternatively spliced mouse transcript to the entire human MCOLN1 genomic sequence and found no significant similarity. As mentioned previously, Northern blots performed with human MCOLN1 probes show only one 2.4 kb transcript. In addition, we hybridized a human multiple tissue Northern and human Southern with a probe in human intron 12 that is adjacent to exon 13. The probe was located in the region syntenic to that which encodes the alternate mouse transcript. Only the expected bands were detected on the Southern and no bands were detected on the Northern, confirming that this alternative transcript is specific to murine Mcoln1. Recent BLASTP analysis of the alternate Mcoln1 transcript yields a match to a putative 145 amino acid anonymous protein (GB No. BAB25862) predicted from a RIKEN clone. It is obvious from our results, however, that the identification of this sequence as a full-length protein is incorrect since probes unique to the clone, as well as probes containing the Mcoln1 coding sequence, identify the same transcripts.
Comparison of Mcoln1 isoform 1 to its human homologue shows striking similarity at both the amino acid and nucleotide level. All six of the transmembrane domains, as well as the putative cation channel are highly conserved. The putative di-leucine (L-L-X-X) motif at the C-terminus, which may act as a late endosomal/lysosomal targeting signal, is also conserved . This speculation is supported by work with cup-5, the c. elegans homologue of MCOLN1, since cellular localization studies suggest that the protein is found in the late endosomes and/or lysosomes.
The mouse Mcoln1 gene has two alternatively spliced isoforms, with isoform 2 having a different c-terminal cytoplasmic tail. The unique 86 amino acid c-terminal tail lacks the lysosomal targeting signal and does not contain any conserved domains when compared against the current profile databases. We speculate that this protein may have similar channel function but an alternate subcellular localization, but this must be proven once isoform-specific antibodies are raised. However, our results suggest that phenotypic assessment of Mcoln1 knock-out mice may be complicated and that care must be taken when interpreting data on mouse gene expression and phenotype.
Interestingly, the second Mcoln1 isoform is not seen in humans and the sequence of the alternatively spliced region is not conserved between man and mouse. To date, very few genes have been reported that show species specific alternative splice variants. MOG, myelin/oligodendrocyte glycoprotein, has many different splice variants in humans that are not found in mice . ATP11B, a P-type ATPase, has a rabbit-specific splice variant that deletes a transmembrane domain and therefore likely alters the putative function of the protein . Sequencing of the human genome has led to estimates of approximately 32,000 genes, a total surprise given the previous significantly higher estimates that were based on the number of expressed sequence tags (ESTs) in the public databases. This apparent disparity suggests a major role for alternative splicing in creating genetic complexity, and has brought the study of splicing regulation to the forefront of molecular genetics. It is likely that an abundance of species-specific splice variants will be identified as the characterization of alternatively spliced transcripts progresses.
Materials and methods
We conducted database searches using BLAST http://www.ncbi.nlm.nih.gov/blast and Draft Human Genome Browser http://genome.ucsc.edu/. Sequences from UniGene http://www.ncbi.nlm.nih.gov/UniGene were used to confirm the Mcoln1 sequence. We performed motif searches using ProfileScan http://www.isrec.isb-sib.ch/software/PFSCAN_form.html and TMPred http://www.ch.embnet.org/software/TMPRED_form.html and alignment of protein sequences using Pileup (GCG) and Boxshade http://www.ch.embnet.org/softward/BOX_form.html.
I.M.A.G.E. Clones were purchased from Research Genetics (Huntsville, AL). Sequencing was performed using the AmpliCycle sequencing kit from Applied Biosystems (Foster City, CA) on a Genomyx LR programmable DNA sequencer.
BALB/c mouse brain total RNA was purchased from Clontech Laboratories (Palo Alto, CA) and made to a 1 μg / ml concentration. This RNA was used as a template to create cDNA via RT-PCR using random hexamers and oligo dT primer. The RT product was used to confirm the alternatively spliced form using primers: 5'-CATCTACCTGGGCTATTGC-3' (forward) and 5'-GCTCTCAGGTGGTGGACAC-3' (reverse) in a PCR reaction with an annealing temperature of 61°C.
Southern Blot Analysis
Total mouse genomic DNA was digested using EcoRI, BamHI, PstI, and XbaI. The digests were electrophoresed on a 1% agarose gel at 60V overnight and were transferred onto a Hybond N+ membrane from Amersham Pharmacia Biotech (Piscataway, NJ). A 32P-dATP labeled PCR fragment of the Mcoln1 coding region corresponding to exon 2 was used as a probe (primers 5'-CCCCACAGAAGAGGAAGAC-3' (forward) and 5'-AGATCTTGACCACCTGCAG-3' (reverse) with an annealing temperature of 59°C). Hybridization and washes were carried out in standard conditions .
Northern Blot Analysis
Mouse embryo multiple-tissue northern blot and mouse adult multiple-tissue northern blot filters were purchased from Clontech Laboratories (Palo Alto, CA). The filters were hybridized with the 32P-dATP labeled DNA fragment of Mcoln1 coding region corresponding to exon 2 (see above). For the alternative transcript, a probe was generated in the region between exons 12 and 13 with primers 5'-GTGTCCACCACCTGAGAG-3' (forward) and 5'-GAAGTAGCATTCCTGCAGGC-3' (reverse) with an annealing temperature of 62°C. The filters were then hybridized with β-actin probes. Hybridizations and washes were carried out in standard conditions, with the stripping of previously bound probes in between .
This work was supported by grant NS39995.
- Amir N, Zlotogora J, Bach G: Mucolipidosis Type IV: Clinical Spectrum and Natural History. Pediatrics. 1987, 79: 953-959.PubMedGoogle Scholar
- Schiffmann R, Dwyer NK, Lubensky IA, Tsokos M, Sutliff VE, Latimer JS, Frei KP, Brady RO, Barton NW, Blanchette-Mackie EJ, Goldin E: Constitive achlorohydria in mucolipidosis type IV. Proc Natl Acad Sci USA. 1998, 95: 1207-1212. 10.1073/pnas.95.3.1207.PubMed CentralView ArticlePubMedGoogle Scholar
- Berman ER, Livni N, Shapira E, Merin S, Levij IS: Congenital corneal clouding with abnormal systemic storage bodies: a new variant of Mucolipidosis. J Pediatr. 1974, 84: 519-526.View ArticlePubMedGoogle Scholar
- Crandall BF, Philippart M, Brown WJ, Blustone DA: Review article: Mucolipidosis IV. Am J Med Genet. 1982, 12: 301-308.View ArticlePubMedGoogle Scholar
- Tellez-Nagel I, Rapin I, Iwamoto T, Johnson AB, Norton WT, Nitowsky H: Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy. Arch Neurol. 1976, 33: 828-835.View ArticlePubMedGoogle Scholar
- Bargal R, Avidan N, Olender T, Asher EB, Zeigler M, Raas-Rothschild A, Frumkin A, Ben-Yoseph O, Friendlender Y, Lancet D, Bach G: Mucolipidosis Type IV: Novel MCOLN1 Mutations in Jewish and Non-Jewish Patients of the Disease in the Ashkenazi Jewish Population. Hum Mutat. 2001, 17: 397-402. 10.1002/humu.1115.View ArticlePubMedGoogle Scholar
- Bargal R, Avidan N, Ben-Asher E, Olender Z, Zeigler M, Frumkin A, Rass-Rothschild A, Glusman G, Lancet D, Bach G: Identification of the gene causing Mucolipidosis type IV. Nat Genet. 2000, 26: 118-123. 10.1038/79095.View ArticlePubMedGoogle Scholar
- Bassi MT, Manzoni M, Monti E, Pizzo MT, Ballabio A, Borsani G: Cloning of the gene encoding a novel integral membrane protein, mucolipidin-1 and identification of the two major founder mutations causing Mucolipidosis type IV. Am J Hum Genet. 2000, 67: 1110-1120.PubMed CentralView ArticlePubMedGoogle Scholar
- Sun M, Goldin E, Stahl S, Falardeau JL, Kennedy JC, Acierno JS, Bove C, Kaneski CR, Nagle J, Bromley MC, Colman M, Schiffmann R, Slaugenhaupt SA: Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet. 2000, 9: 2471-2478. 10.1093/hmg/9.17.2471.View ArticlePubMedGoogle Scholar
- Slaugenhaupt SA, Acierno JS, Helbling LA, Bove C, Goldin E, Bach G, Schiffmann R, Gusella JF: Mapping of the Mucolipidosis type IV gene to chromosome 19p and defining the founder haplotype. Am J Hum Genet. 1999, 65: 773-778. 10.1086/302549.PubMed CentralView ArticlePubMedGoogle Scholar
- Bargal R, Bach G: Mucolipidosis type IV: abnormal transport of lipids to lysosomes. J Inherit Metab Dis. 1997, 20: 625-632. 10.1023/A:1005362123443.View ArticlePubMedGoogle Scholar
- Chen CS, Bach G, Pagano RE: Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci. 1998, 95: 6373-6378. 10.1073/pnas.95.11.6373.PubMed CentralView ArticlePubMedGoogle Scholar
- Fares H, Greenwald I: Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. Nat Genet. 2001, 28: 64-68. 10.1038/88281.PubMedGoogle Scholar
- Kim J, Gordon L, Dehal P, Badri H, Christensen M, Groza M, Ha C, Hammond S, Vargas M, Wehri E, Wagner M, Olsen A, Stubbs L: Homology-driven assembly of a sequence-ready mouse BAC contig map spanning regions related to the 46-Mb gene-rich euchromatic segments of human chromosome 19. Genomics. 2001, 74: 129-141. 10.1006/geno.2001.6521.View ArticlePubMedGoogle Scholar
- Acierno JS, Kennedy JC, Falardeau JL, Leyne M., Bromley MC, Colman MW, Sun M, Bove C, Ashworth LK, Chadwik LH, Schiripo T, Ma S, Goldin E, Schiffmann R, Slaugenhaupt SA: A Physical and Transcript Map of the MCOLN1 Gene Region on Human Chromosome 19p13.3-13.2. Genomics. 2001, 73: 203-210. 10.1006/geno.2001.6526.View ArticlePubMedGoogle Scholar
- Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. Cold Spring Harbor, Cold Spring Harbor Laboratory Press. 1989Google Scholar
- Ballenthin PA, Gardinier MV: Myelin/oligodendrocyte glycoprotein is alternatively spliced in humans but not mice. J Neurosci Res. 1996, 46: 271-281. 10.1002/(SICI)1097-4547(19961015)46:2<271::AID-JNR16>3.0.CO;2-5.View ArticlePubMedGoogle Scholar
- Halleck MS, Schlegel RA, Williamson P: Re-analysis of ATP11B, a type IV P type ATPase. J Biol Chem. 2002,Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.